Retrospective study of a TTR FAP cohort to modify NIS + 7 for therapeutic trials

N. Suanprasert, J. L. Berk, Merrill Benson, P. J B Dyck, C. J. Klein, J. A. Gollob, B. R. Bettencourt, V. Karsten, P. J. Dyck

Research output: Contribution to journalArticle

38 Citations (Scopus)

Abstract

Protein stabilization and oligonucleotide therapies are being tested in transthyretin amyloid polyneuropathy (TTR FAP) trials. From retrospective analysis of 97 untreated TTR FAP patients, we test the adequacy of Neuropathy Impairment Score + 7 tests (NIS + 7) and modifications to comprehensively score impairments for use in such therapeutic trials. Our data confirms that TTR FAP usually is a sensorimotor polyneuropathy with autonomic features which usually is symmetric, length dependent, lower limb predominant and progressive. NIS + 7 adequately assesses weakness and muscle stretch reflexes without ceiling effects but not sensation loss, autonomic dysfunction or nerve conduction abnormalities. Three modifications of NIS + 7 are suggested: 1) use of Smart Somatotopic Quantitative Sensation Testing (S ST QSTing); 2) choice of new autonomic assessments, e.g., sudomotor testing of distributed anatomical sites; and 3) use of only compound muscle action potential amplitudes (of ulnar, peroneal and tibial nerves) and sensory nerve action potentials of ulnar and sural nerve - than the previously recommended attributes suggested for the sensitive detection of diabetic sensorimotor polyneuropathy. These modifications of NIS + 7 if used in therapeutic trials should improve characterization and quantification of sensation and autonomic impairment in TTR FAP and provide better nerve conduction tests.

Original languageEnglish
Pages (from-to)121-128
Number of pages8
JournalJournal of the Neurological Sciences
Volume344
Issue number1-2
DOIs
StatePublished - Sep 15 2014

Fingerprint

Ulnar Nerve
Retrospective Studies
Neural Conduction
Action Potentials
Amyloid Neuropathies
Stretch Reflex
Tibial Nerve
Sural Nerve
Peroneal Nerve
Prealbumin
Polyneuropathies
Diabetic Neuropathies
Muscle Weakness
Oligonucleotides
Lower Extremity
Therapeutics
Muscles
Proteins

Keywords

  • Ceiling effects
  • Neuropathy Impairment Score (NIS)
  • Polyneuropathy signs and tests
  • Smart Somatotopic QSTing
  • Transthyretin amyloidosis polyneuropathy (TTR FAP)

ASJC Scopus subject areas

  • Clinical Neurology
  • Neurology
  • Medicine(all)

Cite this

Suanprasert, N., Berk, J. L., Benson, M., Dyck, P. J. B., Klein, C. J., Gollob, J. A., ... Dyck, P. J. (2014). Retrospective study of a TTR FAP cohort to modify NIS + 7 for therapeutic trials. Journal of the Neurological Sciences, 344(1-2), 121-128. https://doi.org/10.1016/j.jns.2014.06.041

Retrospective study of a TTR FAP cohort to modify NIS + 7 for therapeutic trials. / Suanprasert, N.; Berk, J. L.; Benson, Merrill; Dyck, P. J B; Klein, C. J.; Gollob, J. A.; Bettencourt, B. R.; Karsten, V.; Dyck, P. J.

In: Journal of the Neurological Sciences, Vol. 344, No. 1-2, 15.09.2014, p. 121-128.

Research output: Contribution to journalArticle

Suanprasert, N, Berk, JL, Benson, M, Dyck, PJB, Klein, CJ, Gollob, JA, Bettencourt, BR, Karsten, V & Dyck, PJ 2014, 'Retrospective study of a TTR FAP cohort to modify NIS + 7 for therapeutic trials', Journal of the Neurological Sciences, vol. 344, no. 1-2, pp. 121-128. https://doi.org/10.1016/j.jns.2014.06.041
Suanprasert, N. ; Berk, J. L. ; Benson, Merrill ; Dyck, P. J B ; Klein, C. J. ; Gollob, J. A. ; Bettencourt, B. R. ; Karsten, V. ; Dyck, P. J. / Retrospective study of a TTR FAP cohort to modify NIS + 7 for therapeutic trials. In: Journal of the Neurological Sciences. 2014 ; Vol. 344, No. 1-2. pp. 121-128.
@article{5faf356075e940b29f29393e4be777c4,
title = "Retrospective study of a TTR FAP cohort to modify NIS + 7 for therapeutic trials",
abstract = "Protein stabilization and oligonucleotide therapies are being tested in transthyretin amyloid polyneuropathy (TTR FAP) trials. From retrospective analysis of 97 untreated TTR FAP patients, we test the adequacy of Neuropathy Impairment Score + 7 tests (NIS + 7) and modifications to comprehensively score impairments for use in such therapeutic trials. Our data confirms that TTR FAP usually is a sensorimotor polyneuropathy with autonomic features which usually is symmetric, length dependent, lower limb predominant and progressive. NIS + 7 adequately assesses weakness and muscle stretch reflexes without ceiling effects but not sensation loss, autonomic dysfunction or nerve conduction abnormalities. Three modifications of NIS + 7 are suggested: 1) use of Smart Somatotopic Quantitative Sensation Testing (S ST QSTing); 2) choice of new autonomic assessments, e.g., sudomotor testing of distributed anatomical sites; and 3) use of only compound muscle action potential amplitudes (of ulnar, peroneal and tibial nerves) and sensory nerve action potentials of ulnar and sural nerve - than the previously recommended attributes suggested for the sensitive detection of diabetic sensorimotor polyneuropathy. These modifications of NIS + 7 if used in therapeutic trials should improve characterization and quantification of sensation and autonomic impairment in TTR FAP and provide better nerve conduction tests.",
keywords = "Ceiling effects, Neuropathy Impairment Score (NIS), Polyneuropathy signs and tests, Smart Somatotopic QSTing, Transthyretin amyloidosis polyneuropathy (TTR FAP)",
author = "N. Suanprasert and Berk, {J. L.} and Merrill Benson and Dyck, {P. J B} and Klein, {C. J.} and Gollob, {J. A.} and Bettencourt, {B. R.} and V. Karsten and Dyck, {P. J.}",
year = "2014",
month = "9",
day = "15",
doi = "10.1016/j.jns.2014.06.041",
language = "English",
volume = "344",
pages = "121--128",
journal = "Journal of the Neurological Sciences",
issn = "0022-510X",
publisher = "Elsevier",
number = "1-2",

}

TY - JOUR

T1 - Retrospective study of a TTR FAP cohort to modify NIS + 7 for therapeutic trials

AU - Suanprasert, N.

AU - Berk, J. L.

AU - Benson, Merrill

AU - Dyck, P. J B

AU - Klein, C. J.

AU - Gollob, J. A.

AU - Bettencourt, B. R.

AU - Karsten, V.

AU - Dyck, P. J.

PY - 2014/9/15

Y1 - 2014/9/15

N2 - Protein stabilization and oligonucleotide therapies are being tested in transthyretin amyloid polyneuropathy (TTR FAP) trials. From retrospective analysis of 97 untreated TTR FAP patients, we test the adequacy of Neuropathy Impairment Score + 7 tests (NIS + 7) and modifications to comprehensively score impairments for use in such therapeutic trials. Our data confirms that TTR FAP usually is a sensorimotor polyneuropathy with autonomic features which usually is symmetric, length dependent, lower limb predominant and progressive. NIS + 7 adequately assesses weakness and muscle stretch reflexes without ceiling effects but not sensation loss, autonomic dysfunction or nerve conduction abnormalities. Three modifications of NIS + 7 are suggested: 1) use of Smart Somatotopic Quantitative Sensation Testing (S ST QSTing); 2) choice of new autonomic assessments, e.g., sudomotor testing of distributed anatomical sites; and 3) use of only compound muscle action potential amplitudes (of ulnar, peroneal and tibial nerves) and sensory nerve action potentials of ulnar and sural nerve - than the previously recommended attributes suggested for the sensitive detection of diabetic sensorimotor polyneuropathy. These modifications of NIS + 7 if used in therapeutic trials should improve characterization and quantification of sensation and autonomic impairment in TTR FAP and provide better nerve conduction tests.

AB - Protein stabilization and oligonucleotide therapies are being tested in transthyretin amyloid polyneuropathy (TTR FAP) trials. From retrospective analysis of 97 untreated TTR FAP patients, we test the adequacy of Neuropathy Impairment Score + 7 tests (NIS + 7) and modifications to comprehensively score impairments for use in such therapeutic trials. Our data confirms that TTR FAP usually is a sensorimotor polyneuropathy with autonomic features which usually is symmetric, length dependent, lower limb predominant and progressive. NIS + 7 adequately assesses weakness and muscle stretch reflexes without ceiling effects but not sensation loss, autonomic dysfunction or nerve conduction abnormalities. Three modifications of NIS + 7 are suggested: 1) use of Smart Somatotopic Quantitative Sensation Testing (S ST QSTing); 2) choice of new autonomic assessments, e.g., sudomotor testing of distributed anatomical sites; and 3) use of only compound muscle action potential amplitudes (of ulnar, peroneal and tibial nerves) and sensory nerve action potentials of ulnar and sural nerve - than the previously recommended attributes suggested for the sensitive detection of diabetic sensorimotor polyneuropathy. These modifications of NIS + 7 if used in therapeutic trials should improve characterization and quantification of sensation and autonomic impairment in TTR FAP and provide better nerve conduction tests.

KW - Ceiling effects

KW - Neuropathy Impairment Score (NIS)

KW - Polyneuropathy signs and tests

KW - Smart Somatotopic QSTing

KW - Transthyretin amyloidosis polyneuropathy (TTR FAP)

UR - http://www.scopus.com/inward/record.url?scp=84914118074&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84914118074&partnerID=8YFLogxK

U2 - 10.1016/j.jns.2014.06.041

DO - 10.1016/j.jns.2014.06.041

M3 - Article

C2 - 25012480

AN - SCOPUS:84914118074

VL - 344

SP - 121

EP - 128

JO - Journal of the Neurological Sciences

JF - Journal of the Neurological Sciences

SN - 0022-510X

IS - 1-2

ER -